Johns Hopkins Technology Ventures logo

Johns Hopkins Technology Ventures

North America, Maryland, United States, Baltimore

Description

JHTV helps develop new discoveries and inventions into products and services that benefit society and transform the world.

Investor Profile

Johns Hopkins Technology Ventures has backed more than 4 startups, with 1 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series Unknown, Pre Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Therapeutics.
  • Led 1 rounds in the past year.

Stage Focus

  • Seed (50%)
  • Series Unknown (25%)
  • Pre Seed (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Therapeutics
  • Oncology
  • Human Resources
  • Information Technology
  • Internet
  • Edtech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Johns Hopkins Technology Ventures frequently co-invest with?

TS
North America, Maryland, United States, Towson
Co-Investments: 1
Co-Investments: 1
TEDCO
North America, Maryland, United States, Columbia
Co-Investments: 1
IP Group
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Johns Hopkins Technology Ventures?

StudentRelay

Wilmington, Delaware, United States

Educational Support Service

EdTech
SeedDec 3, 2024
Amount Raised: $750,000
Fem Equity

Baltimore, Maryland, United States

Fem Equity is an workplace platform that creates solutions for women and underrepresented professionals going through pay gaps in real-time.

Human ResourcesInformation TechnologyInternet
Pre SeedJun 9, 2023
Lorem Therapeutics

Baltimore, Maryland, United States

Lorem Tx is a drug discovery company translating innovative drugs from Johns Hopkins University.

BiotechnologyPharmaceuticalTherapeutics
SeedMay 14, 2018
Avidea Technologies

Baltimore, Maryland, United States

Avidea Technologies is a developer of polymer-based drugs intended to provide vaccines for cancer treatment and infectious diseases.

BiotechnologyOncology
Series UnknownJan 1, 2018